Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor

Obesity has been classified as a disease that affects many people around the globe including Malaysia. The prevalence continues to rise each year, thus finding an effective and safe treatment as an anti-obesity drug is a major issue to researchers. At present, the only anti-obesity that gained appro...

Full description

Bibliographic Details
Main Authors: Ghazali, Siti Nur Akmal, Alias, Norsyuhada, Abdul Hamid, Azzmer Azzar
Format: Conference or Workshop Item
Language:English
Published: 2017
Subjects:
Online Access:http://irep.iium.edu.my/54635/
http://irep.iium.edu.my/54635/
http://irep.iium.edu.my/54635/6/Biomed%20sympo%202017.pdf
id iium-54635
recordtype eprints
spelling iium-546352017-11-21T03:54:32Z http://irep.iium.edu.my/54635/ Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor Ghazali, Siti Nur Akmal Alias, Norsyuhada Abdul Hamid, Azzmer Azzar RM Therapeutics. Pharmacology Obesity has been classified as a disease that affects many people around the globe including Malaysia. The prevalence continues to rise each year, thus finding an effective and safe treatment as an anti-obesity drug is a major issue to researchers. At present, the only anti-obesity that gained approval by the Food and Drug Administration (FDA) is Orlistat. It acts by inhibiting pancreatic lipase activity. Unfortunately it is a synthetic drug and comes with unpleasant side-effects. Hence, there is a need to search for pancreatic lipase inhibitor from natural resources. Several studies have revealed that flavonoids from Nelumbo nucifera leaves extract showed pancreatic lipase-inhibitory activity. In this study flavonoids from N. nucifera namely leucoanthocyadin, rutin and astragalin were chosen to undergo molecular docking analysis using AutoDock 4.2. Molecular docking is an in silico method to predict the binding site of the selected compounds towards pancreatic lipase structure. Docking simulation revealed that astragalin displayed the best affinity towards pancreatic lipase as compared to the other two flavonoids. Astragalin produced more hydrogen bonds and had lower free binding energy compared to orlistat. Moreover, astragalin formed strong hydrogen bond with key amino acid Ser 152 in the catalytic triad and showed good ligand recognition as it also had strong hydrogen bond with His 151, Phe 215 and Arg 256. This preliminary in silico result proposes that astragalin might act as an anti-obesity agent through pancreatic lipase inhibition action. 2017-05-12 Conference or Workshop Item NonPeerReviewed application/pdf en http://irep.iium.edu.my/54635/6/Biomed%20sympo%202017.pdf Ghazali, Siti Nur Akmal and Alias, Norsyuhada and Abdul Hamid, Azzmer Azzar (2017) Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor. In: 8th Malaysian Symposium of Biomedical Science, 12th-14th May 2017, Kuantan, Pahang. (Unpublished) http://primanexus.com.my/events/8th-malaysian-symposium-of-biomedical-science
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RM Therapeutics. Pharmacology
spellingShingle RM Therapeutics. Pharmacology
Ghazali, Siti Nur Akmal
Alias, Norsyuhada
Abdul Hamid, Azzmer Azzar
Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
description Obesity has been classified as a disease that affects many people around the globe including Malaysia. The prevalence continues to rise each year, thus finding an effective and safe treatment as an anti-obesity drug is a major issue to researchers. At present, the only anti-obesity that gained approval by the Food and Drug Administration (FDA) is Orlistat. It acts by inhibiting pancreatic lipase activity. Unfortunately it is a synthetic drug and comes with unpleasant side-effects. Hence, there is a need to search for pancreatic lipase inhibitor from natural resources. Several studies have revealed that flavonoids from Nelumbo nucifera leaves extract showed pancreatic lipase-inhibitory activity. In this study flavonoids from N. nucifera namely leucoanthocyadin, rutin and astragalin were chosen to undergo molecular docking analysis using AutoDock 4.2. Molecular docking is an in silico method to predict the binding site of the selected compounds towards pancreatic lipase structure. Docking simulation revealed that astragalin displayed the best affinity towards pancreatic lipase as compared to the other two flavonoids. Astragalin produced more hydrogen bonds and had lower free binding energy compared to orlistat. Moreover, astragalin formed strong hydrogen bond with key amino acid Ser 152 in the catalytic triad and showed good ligand recognition as it also had strong hydrogen bond with His 151, Phe 215 and Arg 256. This preliminary in silico result proposes that astragalin might act as an anti-obesity agent through pancreatic lipase inhibition action.
format Conference or Workshop Item
author Ghazali, Siti Nur Akmal
Alias, Norsyuhada
Abdul Hamid, Azzmer Azzar
author_facet Ghazali, Siti Nur Akmal
Alias, Norsyuhada
Abdul Hamid, Azzmer Azzar
author_sort Ghazali, Siti Nur Akmal
title Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
title_short Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
title_full Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
title_fullStr Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
title_full_unstemmed Molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
title_sort molecular docking of selected flavonoid compounds from nelumbo nucifera as potential pancreatic lipase inhibitor
publishDate 2017
url http://irep.iium.edu.my/54635/
http://irep.iium.edu.my/54635/
http://irep.iium.edu.my/54635/6/Biomed%20sympo%202017.pdf
first_indexed 2023-09-18T21:17:17Z
last_indexed 2023-09-18T21:17:17Z
_version_ 1777411646933696512